On the other hand, some CRC biomarkers identified from previous studies, such as CTNNB1 (14), S100A4 (67), and EPAS1 (68) were also detected in this study with similar dysregulation patterns, but there was an insufficient sample size in this study that led to these biomarkers being statistically insignificant. This evidence concerns the gene CTNNB1 and colorectal carcinoma.